[
  {
    "ts": null,
    "headline": "COO or WST: Which Is the Better Value Stock Right Now?",
    "summary": "COO vs. WST: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=b05963fe669039c1e22e68b85f993a6a65f6ce8f11dfb3ec9145d15bee960fe9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768236003,
      "headline": "COO or WST: Which Is the Better Value Stock Right Now?",
      "id": 138078232,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "COO vs. WST: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=b05963fe669039c1e22e68b85f993a6a65f6ce8f11dfb3ec9145d15bee960fe9"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States",
    "summary": "AbbVie (NYSE: ABBV) and West Pharmaceutical Services (NYSE: WST) announced today a definitive agreement for AbbVie to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property from West. The acquisition of the manufacturing site will significantly expand AbbVie's drug delivery device manufacturing capabilities and capacity.",
    "url": "https://finnhub.io/api/news?id=ac8939b079978297f76c5203c80b3d85f43c27989f0f3359a46d90ef9f10ea61",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768215600,
      "headline": "AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States",
      "id": 138071380,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) and West Pharmaceutical Services (NYSE: WST) announced today a definitive agreement for AbbVie to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property from West. The acquisition of the manufacturing site will significantly expand AbbVie's drug delivery device manufacturing capabilities and capacity.",
      "url": "https://finnhub.io/api/news?id=ac8939b079978297f76c5203c80b3d85f43c27989f0f3359a46d90ef9f10ea61"
    }
  },
  {
    "ts": null,
    "headline": "West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose速 3.5mL On-Body Delivery System to AbbVie",
    "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the company has reached a definitive agreement to sell all manufacturing and supply rights for SmartDose速 3.5mL On-Body Delivery System and associated facilities to AbbVie (NYSE: ABBV) for total consideration of $112.5 million at close, subject to working capital and other adjustments. The definitive agreement, which is subject to certain closing condit",
    "url": "https://finnhub.io/api/news?id=eee722e6bd9a5d798dc451e61f082eb755157a413dff8ba85c2570e2848aa6a2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768215600,
      "headline": "West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose速 3.5mL On-Body Delivery System to AbbVie",
      "id": 138071379,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the company has reached a definitive agreement to sell all manufacturing and supply rights for SmartDose速 3.5mL On-Body Delivery System and associated facilities to AbbVie (NYSE: ABBV) for total consideration of $112.5 million at close, subject to working capital and other adjustments. The definitive agreement, which is subject to certain closing condit",
      "url": "https://finnhub.io/api/news?id=eee722e6bd9a5d798dc451e61f082eb755157a413dff8ba85c2570e2848aa6a2"
    }
  }
]